In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting

Gloria Krapež(University of Ljubljana), Ivana Jovčevska(University of Ljubljana), Rok Romih(University of Ljubljana), Igor Križaj(Jožef Stefan Institute), Ana Kump(Jožef Stefan Institute), Jurij Stojan(University of Ljubljana), Alja Zottel(University of Ljubljana), Matej Butala(University of Ljubljana), Gregor Bajc(University of Ljubljana), Jernej Šribar(Jožef Stefan Institute), Neja Šamec(University of Ljubljana), Mojca Katrašnik(University of Ljubljana), Serge Muyldermans(Vrije Universiteit Brussel)
Antibodies
January 24, 2025
Cited by 2


Related Papers